| Immune checkpoint inhibitors in cancer therapy Y Shiravand, F Khodadadi, SMA Kashani, SR Hosseini-Fard, S Hosseini, ... Current Oncology 29 (5), 3044-3060, 2022 | 461 | 2022 |
| A comprehensive overview of coagulation factor V and congenital factor V deficiency S Tabibian, Y Shiravand, M Shams, M Safa, MS Gholami, F Heydari, ... Seminars in thrombosis and hemostasis 45 (05), 523-543, 2019 | 81 | 2019 |
| Platelet phenotyping and function testing in thrombocytopenia K Jurk, Y Shiravand Journal of Clinical Medicine 10 (5), 1114, 2021 | 22 | 2021 |
| Understanding the tumor microenvironment in head and neck squamous cell carcinoma HS Rad, Y Shiravand, P Radfar, R Ladwa, C Perry, X Han, ME Warkiani, ... Clinical & Translational Immunology 11 (6), e1397, 2022 | 17 | 2022 |
| The Pandora’s box of novel technologies that may revolutionize lung cancer HS Rad, HS Rad, Y Shiravand, P Radfar, D Arpon, ME Warkiani, ... Lung Cancer 159, 34-41, 2021 | 17 | 2021 |
| von Willebrand disease A Dorgalaleh, S Tabibian, Y Shiravand, EJ Favaloro Congenital Bleeding Disorders: Diagnosis and Management, 57-102, 2018 | 9 | 2018 |
| Fine-Tuning of Platelet Responses by Serine/Threonine Protein Kinases and Phosphatases—Just the Beginning Y Shiravand, U Walter, K Jurk Hämostaseologie 41 (03), 206-216, 2021 | 8 | 2021 |
| Congenital factor XI deficiency, complete genotype and phenotype of two Iranian families A Dorgalaleh, M Gholaminezhad, Y Shiravand, M Naderi, M Safa Blood Coagulation & Fibrinolysis 30 (8), 409-412, 2019 | 5 | 2019 |
| Oxidative stress changes in blood bags in consecutive weeks after donation S Barzegar, F Nadali, AA Pourfatollah, AR Abbaspour, S Farokhinia, ... Scientific Journal of Iran Blood Transfus Organ 13 (1), 11-18, 2016 | 5 | 2016 |
| Hemostasis critical values among Iranian clinical laboratories “National Survey of 157 Clinical Laboratories” A Dorgalaleh, Y Shiravand, A Dabbagh, S Tabibian, MS Hosseini, ... International Journal of Laboratory Hematology 41 (6), 778-781, 2019 | 4 | 2019 |
| Glanzmann thrombasthenia A Dorgalaleh, MC Poon, Y Shiravand Congenital Bleeding Disorders: Diagnosis and Management, 327-355, 2018 | 4 | 2018 |
| Mitofusin-2 in cancer: Friend or foe? P Ramaiah, I Patra, A Abbas, AA Fadhil, M Abohassan, ZH Al-Qaim, ... Archives of Biochemistry and Biophysics 730, 109395, 2022 | 2 | 2022 |
| A large deletion, spanning exons 1 to 25 of F8 gene, and a high‐titer factor VIII inhibitor, in severe hemophilia A. SH Mousavi, SA Mesbah‐Namin, S Zeinali, M Jazebi, A Dabbagh, ... International Journal of Laboratory Hematology 42 (3), 2020 | 2 | 2020 |
| Spatial Transcriptomic Approaches for Understanding the Tumor Microenvironment (TME) HS Rad, Y Shiravand, P Radfar, R Ladwa, ME Warkiani, K O’Byrne, ... Cancer Research: An Interdisciplinary Approach, 49-77, 2023 | 1 | 2023 |
| EVALUATION OF SPLENCTOMY VALUE IN PATIENTS WITH AUTOIMMUNE CYTOPENIC PURPURA THAT REFER TO SPECIALTY IMAM REZA HOSPITAL BETWEEN 2005-2015 H JALAEIKHOO, M RAJAEINEJAD, M KAYHANI, Y SHIRAVAND, ... IRANIAN JOURNAL OF SURGERY 25 (3), 54-60, 2017 | | 2017 |
| Evaluation of pro-oxidant-antioxidant balance (PAB) in blood storage in consecutive weeks after donation S Barzegar, F Nadali, AA Pourfatollah, AR Abbaspour, S Farokhinia, ... Journal of North Khorasan University of Medical Sciences 7 (1), 37-44, 2015 | | 2015 |
| The role of rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis strains T Sabooteh, Y Shiravand | | 2014 |
| and Emmanuel J. Favaloro A Dorgalaleh, S Tabibian, Y Shiravand Congenital Bleeding Disorders, 57, 0 | | |
| Vol. 159, September 2021 WCM Dempke, M Reck, HS Rad, Y Shiravand, P Radfar, D Arpon, ... | | |
| Quality of life, depression, anxiety and stress in over-18-year-old patients with beta-Thalassemia major S Barzegar, F Nadali, AA Pourfatollah, AR Abbaspour, S Farokhinia, ... | | |
Mohammad Saeed GholamiDepartment of Hematology and Blood Transfusion, Iran University of Medical Sciences在 tak.iums.ac.ir 的电子邮件经过验证
